Patents by Inventor Eric Bornstein

Eric Bornstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10702706
    Abstract: Systems and methods are disclosed herein for prophylactic application of near-infrared optical energies and dosimetries to photo-biologically inhibit accelerations or intensifications in biofilm production, after a bacterial or fungal pathogen is challenged with an antibiotic or antifungal agent. This photo-biologic minimum biofilm inhibitory concentration (PMBIC) of infrared light will lower the minimum inhibitory concentration (MIC) necessary of an antibiotic and/or antifungal molecule necessary to decrease bacterial and fungal pathogens in human tissues. These systems and methods will only target undesirable microbial cells.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: July 7, 2020
    Assignee: NOMIR MEDICAL TECHNOLOGIES, INC.
    Inventor: Eric Bornstein
  • Publication number: 20180264282
    Abstract: Nasal colonisation with pathogenic bacteria continues to present challenges for patients undergoing surgical procedures, and the physicans that treat them. Many physicians and scientists have discussed different ways to improve nasal decolonization in the last 100 years. Various embodiments include a medical kit composed of items specifically tailored to assist in the photo-biologic eradication of bacteria in the human nares.
    Type: Application
    Filed: March 15, 2018
    Publication date: September 20, 2018
    Inventor: Eric Bornstein
  • Patent number: 9517355
    Abstract: A method is disclosed of providing photo-chrono-therapy to a wound site in a human or animal subject, the method including: determining or receiving subject circadian and/or ultradian cycle information indicative of a biological rhythm(s) of the subject; and based on the subject cycle information, delivering a photo-chrono-dose of infrared treatment light to the wound site with wavelengths within at least one infrared wavelength range and having a dosimetry configured to promote healing at the wound site.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: December 13, 2016
    Assignee: NOMIR MEDICAL TECHNOLOGIES, INC.
    Inventor: Eric Bornstein
  • Publication number: 20150306417
    Abstract: Systems and methods are disclosed herein for applying near-infrared optical energies and dosimetries to alter the bioenergetic steady-state trans-membrane and mitochondrial potentials (??-steady) of all irradiated cells through an optical depolarization effect. This depolarization causes a concomitant decrease in the absolute value of the trans-membrane potentials ?? of the irradiated mitochondrial and plasma membranes. Many cellular anabolic reactions and drug-resistance mechanisms can be rendered less functional and/or mitigated by a decrease in a membrane potential ??, the affiliated weakening of the proton motive force ?p, and the associated lowered phosphorylation potential ?Gp. Within the area of irradiation exposure, the decrease in membrane potentials ?? will occur in bacterial, fungal and mammalian cells in unison. This membrane depolarization provides the ability to potentiate antimicrobial, antifungal and/or antineoplastic drugs against only targeted undesirable cells.
    Type: Application
    Filed: March 24, 2015
    Publication date: October 29, 2015
    Inventor: Eric BORNSTEIN
  • Publication number: 20150202459
    Abstract: Optical methods and devices are provided for the reduction of the lipid content of adipocytes without significant heat or intolerable adverse effect on the cells and their surrounding tissues. The optical method and device can be used to irradiate adipose tissue through the skin with non-thermal and non-destructive effects by application of near infrared (NIR) irradiation at selected wave bands in selected ranges to affect modulation of innate enzymatic processes involved in lipolysis, lipogenesis, leptin secretion, adiponectin secretion, and/or glucose absorption.
    Type: Application
    Filed: November 14, 2014
    Publication date: July 23, 2015
    Inventor: ERIC BORNSTEIN
  • Publication number: 20150157714
    Abstract: Systems and methods for treating a pathogenic bacterial infection are provided. The treatment may include introducing bioluminescent bacteria into a lung of a human or animal subject, and performing photodynamic therapy on the lung using light emitted from the bioluminescent bacteria.
    Type: Application
    Filed: December 11, 2014
    Publication date: June 11, 2015
    Inventor: Eric BORNSTEIN
  • Publication number: 20150157876
    Abstract: Systems and methods are disclosed herein for applying near-infrared optical energies and dosimetries to alter the bioenergetic steady-state trans-membrane and mitochondrial potentials (??-steady) of all irradiated cells through an optical depolarization effect. This depolarization causes a concomitant decrease in the absolute value of the trans-membrane potentials ?? of the irradiated mitochondrial and plasma membranes. Many cellular anabolic reactions and drug-resistance mechanisms can be rendered less functional and/or mitigated by a decrease in a membrane potential ??, the affiliated weakening of the proton motive force ?p, and the associated lowered phosphorylation potential ?Gp. Within the area of irradiation exposure, the decrease in membrane potentials ?? will occur in bacterial, fungal and mammalian cells in unison. This membrane depolarization provides the ability to potentiate antimicrobial, antifungal and/or antineoplastic drugs against only targeted undesirable cells.
    Type: Application
    Filed: October 7, 2014
    Publication date: June 11, 2015
    Inventors: Eric BORNSTEIN, John Wlassich
  • Patent number: 8983257
    Abstract: An optical delivery apparatus is disclosed including: an optical fiber extending between a distal end having a distal end face and a proximal end having a proximal end face, an optical element positioned to receive the light emitted from the distal end face and direct the light to an illumination region; and a non-metallic housing containing the optical fiber and the optical element and maintaining the relative position of the optical fiber and the optical element.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: March 17, 2015
    Assignee: Nomir Medical Technologies, Inc.
    Inventors: Eric Bornstein, Edward Sinofsky
  • Publication number: 20150057598
    Abstract: A kit for treating an antimicrobial resistant biological contaminate at a treatment site is disclosed which includes a diffuser tip adapted to receive near infrared therapeutic light from a light delivery system and diffuse the light to illuminate at least a portion of the treatment site; a quantity of an antimicrobial; agent; instructions to use the antimicrobial agent in conjunction with the therapeutic light to potentiate the antimicrobial agent to treat the biological contaminate, and suitable packaging.
    Type: Application
    Filed: September 5, 2014
    Publication date: February 26, 2015
    Inventor: Eric Bornstein
  • Publication number: 20150056568
    Abstract: Methods and devices for Live Biofilm Targeted Thermolysis (LBTT) are disclosed. The disclosed LBTT methods can be used for thermolysis and coagulation of the live periodontal Biofilm with incandescent light and a targeting agent as heat sink. A delivery assembly can be used to deliver the incandescent light generated through the secondary quantum optical and thermal emissions from a carbonized near infrared diode laser delivery fiber, otherwise known as a “hot tip,” to an application region that includes live biofilm. With this novel targeted approach of exploiting the incandescent hot tip's radiant energy (i.e. its optical and thermal emissions), the physical nature of the targeted live biofilm in the periodontal pocket is changed from a mucinous liquid-gel, to a semi-solid coagulum, which then facilitates its removal from the effected pocket, with traditional mechanical SRP periodontal techniques.
    Type: Application
    Filed: September 8, 2014
    Publication date: February 26, 2015
    Inventor: Eric BORNSTEIN
  • Publication number: 20150025439
    Abstract: Systems and methods are disclosed herein for prophylactic application of near-infrared optical energies and dosimetries to photo-biologically inhibit accelerations or intensifications in biofilm production, after a bacterial or fungal pathogen is challenged with an antibiotic or antifungal agent. This photo-biologic minimum biofilm inhibitory concentration (PMBIC) of infrared light will lower the minimum inhibitory concentration (MIC) necessary of an antibiotic and/or antifungal molecule necessary to decrease bacterial and fungal pathogens in human tissues. These systems and methods will only target undesirable microbial cells.
    Type: Application
    Filed: July 16, 2014
    Publication date: January 22, 2015
    Inventor: Eric BORNSTEIN
  • Publication number: 20150025599
    Abstract: A method is disclosed of providing photo-chrono-therapy to a wound site in a human or animal subject, the method including: determining or receiving subject circadian and/or ultradian cycle information indicative of a biological rhythm(s) of the subject; and based on the subject cycle information, delivering a photo-chrono-dose of infrared treatment light to the wound site with wavelengths within at least one infrared wavelength range and having a dosimetry configured to promote healing at the wound site.
    Type: Application
    Filed: August 8, 2014
    Publication date: January 22, 2015
    Inventor: Eric BORNSTEIN
  • Publication number: 20140212331
    Abstract: Methods, systems, and apparatus for Near Infrared Microbial Elimination Laser Systems (NIMELS) including use with medical devices are disclosed. The medical devices can be situated in vivo. Suitable medical devices include catheters, stents, artificial joints, and the like. NIMELS methods, systems, and apparatus can apply near infrared radiant energy of certain wavelengths and dosimetries capable of impairing biological contaminants without intolerable risks and/or adverse effects to biological moieties other than a targeted biological contaminant associated with traditional approaches described in the art (e.g., loss of viability, or thermolysis). Lasers including diode lasers may be used for one or more light sources. A delivery assembly can be used to deliver the optical radiation produced by the source(s) produced to an application region that can include patient tissue. Exemplary embodiments utilize light in a range of 850 nm-900 nm and/or 905 nm-945 nm at suitable NIMELS dosimetries.
    Type: Application
    Filed: September 17, 2013
    Publication date: July 31, 2014
    Applicant: NOMIR MEDICAL TECHNOLOGIES, INC.
    Inventor: Eric BORNSTEIN
  • Publication number: 20130345146
    Abstract: Systems and methods are disclosed herein for applying near-infrared optical energies and dosimetries to alter the bioenergetic steady-state trans-membrane and mitochondrial potentials (??-steady) of all irradiated cells through an optical depolarization effect. This depolarization causes a concomitant decrease in the absolute value of the trans-membrane potentials ?? of the irradiated mitochondrial and plasma membranes. Many cellular anabolic reactions and drug-resistance mechanisms can be rendered less functional and/or mitigated by a decrease in a membrane potential ??, the affiliated weakening of the proton motive force ?p, and the associated lowered phosphorylation potential ?Gp. Within the area of irradiation exposure, the decrease in membrane potentials ?? will occur in bacterial, fungal and mammalian cells in unison. This membrane depolarization provides the ability to potentiate antimicrobial, antifungal and/or antineoplastic drugs against only targeted undesirable cells.
    Type: Application
    Filed: August 12, 2013
    Publication date: December 26, 2013
    Applicant: NOMIR MEDICAL TECHNOLOGIES, INC.
    Inventor: Eric Bornstein
  • Publication number: 20130338739
    Abstract: Optical methods and devices are provided for the reduction of the lipid content of adipocytes without significant heat or intolerable adverse effect on the cells and their surrounding tissues. The optical method and device can be used to irradiate adipose tissue through the skin with non-thermal and non-destructive effects by application of near infrared (NIR) irradiation at selected wave bands in selected ranges to affect modulation of innate enzymatic processes involved in lipolysis, lipogenesis, leptin secretion, adiponectin secretion, and/or glucose absorption.
    Type: Application
    Filed: April 29, 2013
    Publication date: December 19, 2013
    Applicant: NOMIR MEDICAL TECHNOLOGIES, INC.
    Inventor: Eric Bornstein
  • Patent number: 8535359
    Abstract: Methods, systems, and apparatus for Near Infrared Microbial Elimination Laser Systems (NIMELS) including use with medical devices are disclosed. The medical devices can be situated in vivo. Suitable medical devices include catheters, stents, artificial joints, and the like. NIMELS methods, systems, and apparatus can apply near infrared radiant energy of certain wavelengths and dosimetries capable of impairing biological contaminants without intolerable risks and/or adverse effects to biological moieties other than a targeted biological contaminant associated with traditional approaches described in the art (e.g., loss of viability, or thermolysis). Lasers including diode lasers may be used for one or more light sources. A delivery assembly can be used to deliver the optical radiation produced by the source(s) produced to an application region that can include patient tissue. Exemplary embodiments utilize light in a range of 850 nm-900 nm and/or 905 nm-945 nm at suitable NIMELS dosimetries.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: September 17, 2013
    Assignee: Nomir Medical Technologies, Inc.
    Inventor: Eric Bornstein
  • Patent number: 8506979
    Abstract: Systems and methods are disclosed herein for applying near-infrared optical energies and dosimetries to alter the bioenergetic steady-state trans-membrane and mitochondrial potentials (??-steady) of all irradiated cells through an optical depolarization effect. This depolarization causes a concomitant decrease in the absolute value of the trans-membrane potentials ?? of the irradiated mitochondrial and plasma membranes. Many cellular anabolic reactions and drug-resistance mechanisms can be rendered less functional and/or mitigated by a decrease in a membrane potential ??, the affiliated weakening of the proton motive force ?p, and the associated lowered phosphorylation potential ?Gp. Within the area of irradiation exposure, the decrease in membrane potentials ?? will occur in bacterial, fungal and mammalian cells in unison. This membrane depolarization provides the ability to potentiate antimicrobial, antifungal and/or antineoplastic drugs against only targeted undesirable cells.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: August 13, 2013
    Assignee: Nomir Medical Technologies, Inc.
    Inventor: Eric Bornstein
  • Patent number: 8430919
    Abstract: Optical methods and devices are provided for the reduction of the lipid content of adipocytes without significant heat or intolerable adverse effect on the cells and their surrounding tissues. The optical method and device can be used to irradiate adipose tissue through the skin with non-thermal and non-destructive effects by application of near infrared (NIR) irradiation at selected wave bands in selected ranges to affect modulation of innate enzymatic processes involved in lipolysis, lipogenesis, leptin secretion, adiponectin secretion, and/or glucose absorption.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: April 30, 2013
    Assignee: Nomir Medical Technologies, Inc.
    Inventor: Eric Bornstein
  • Publication number: 20120319010
    Abstract: An optical delivery apparatus is disclosed including: an optical fiber extending between a distal end having a distal end face and a proximal end having a proximal end face, an optical element positioned to receive the light emitted from the distal end face and direct the light to an illumination region; and a non-metallic housing containing the optical fiber and the optical element and maintaining the relative position of the optical fiber and the optical element.
    Type: Application
    Filed: May 17, 2012
    Publication date: December 20, 2012
    Inventors: Eric BORNSTEIN, Edward SINOFSKY
  • Publication number: 20120156635
    Abstract: Methods and devices for Live Biofilm Targeted Thermolysis (LBTT) are disclosed. The disclosed LBTT methods can be used for thermolysis and coagulation of the live periodontal Biofilm with incandescent light and a targeting agent as heat sink. A delivery assembly can be used to deliver the incandescent light generated through the secondary quantum optical and thermal emissions from a carbonized near infrared diode laser delivery fiber, otherwise known as a ‘hot tip,’ to an application region that includes live biofilm. With this novel targeted approach of exploiting the incandescent hot tip's radiant energy (ie. its optical and thermal emissions), the physical nature of the targeted live biofilm in the periodontal pocket is changed from a mucinous liquid-gel, to a semi-solid coagulum, which then facilitates its removal from the effected pocket, with traditional mechanical SRP periodontal techniques.
    Type: Application
    Filed: July 25, 2011
    Publication date: June 21, 2012
    Inventor: Eric BORNSTEIN